Rational Fluid Therapy in Germany
This trial is active, not recruiting.
|Condition||patients in icu|
|Sponsor||Ludwig-Maximilians - University of Munich|
|Collaborator||University Hospital Muenster|
|Start date||May 2010|
|End date||May 2011|
|Trial size||4000 participants|
|Trial identifier||NCT01122277, 337 -09/2009-366-f-S|
The purpose of this observational study is the prospective documentation and evaluation of the status quo of volume therapy in German intensive care units.
|United States||No locations recruiting|
|Other countries||No locations recruiting|
Male or female participants at least 18 years old.
Inclusion Criteria: - ICU patients with an indication for fluid/volume therapy Exclusion Criteria: - Patients hospitalized by order of a court of law or a government agency
|Official title||Klinisches Register RaFTinG - Rational Fluid Therapy in Germany|
|Principal investigator||Matthias Jacob, MD|
|Description||The purpose of RaFTinG is the prospective documentation and evaluation of the demographic, diagnostic and therapeutic characteristics of unselected patients and their treatment in intensive care units (ICU) in Germany. Documentation will not only include their stay in the ICU but a follow up query 90 days after discharge from the ICU.|
Call for more information